Tag Archive for: non-melanoma skin cancer treatments

Emerging Squamous Cell and Basal Cell Cancer Treatments: Challenges and Promises

Bookmark (0)

No account yet? Register

Emerging Squamous Cell and Basal Cell Cancer Treatments: Challenges and Promises from Patient Empowerment Network on Vimeo.

What’s the latest in non-melanoma skin cancer treatments? Expert Dr. Silvina Pugliese from Stanford Cancer Center shares updates about immunotherapies, PD-1 inhibitors, hedgehog inhibitors, and anti-PD-1 therapies. 

Silvina Pugliese, M.D., is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. Learn more about Dr. Pugliese.

[ACT]IVATION TIP

“…if you have an advanced squamous cell or basal cell cancer, to ask your oncologist or your treating dermatologists, whether they are aware of any ongoing clinical trials that are being studied in this realm to answer the question of adjuvant and neoadjuvant use of systemic therapies and the treatment of squamous cell cancer and basal cell cancer.”

Download Guide  |  Download Guide en español

See More from [ACT]IVATED Non-Melanoma Skin Cancer

Related Resources:

Non-Melanoma Skin Cancers and Clinical Trials | Advancing Science for Everyone

Non-Melanoma Skin Cancers and Clinical Trials | Advancing Science for Everyone

What Should Non-Melanoma Skin Cancer Patients Consider About Treatment?

What Should Non-Melanoma Skin Cancer Patients Consider About Treatment?

Do Non-Melanoma Skin Cancers Differ in Diverse Patient Populations?

Do Non-Melanoma Skin Cancers Differ in Diverse Patient Populations?


Transcript:

Mary Leer:

Dr. Pugliese, what squamous cell cancer and basal cell cancer data or what studies coming out of major medical conferences are you most excited about and speak to the challenges and the promises of emerging treatments in non-melanoma skin cancers?

Dr. Silvina Pugliese:

Well, there’s a lot of excitement in treatment of squamous cell cancer and basal cell cancer. Most of what we are studying currently in terms of systemic management of advanced squamous cell cancer or squamous cell cancer that can’t be completely removed with surgery or whether it is metastatic disease away from the area of the primary squamous cell cancer. Most of the treatments that are being looked at now are in the category of immunotherapy.

So the immunotherapeutic agents that are being studied currently, the most common ones are cemiplimab (Libtayo) and pembrolizumab (Keytruda). Well, the ones I should say that are being used now. The most common ones are cemiplimab and pembrolizumab, but there are other PD-1 inhibitors being studied for the use of treatment of advanced squamous cell cancer. There are also some studies looking at neoadjuvant treatment. So, treatment in conjunction with surgery, for example, or also, immunotherapy being utilized in conjunction with radiation therapy.

For basal cell cancer, there’s ongoing research in the use of hedgehog inhibitors, including various dosing regimens for two best known hedgehog inhibitors, vismodegib (Erivedge) and sonidegib (Odomzo), as well as the neoadjuvant use of hedgehog inhibitors. And then there are other hedgehog inhibitors being tested, which is important for some patients who do become resistant to vismodegib (Erivedge).

And there’s also ongoing research in the use of immunotherapy to treat basal cell carcinoma. So again, looking at anti-PD-1 therapies, to treat basal cell cancers. My activation tip for this question is that if you have an advanced squamous cell or basal cell cancer, to ask your oncologist or your treating dermatologists, whether they are aware of any ongoing clinical trials that are being studied in this realm to answer the question of adjuvant and neoadjuvant use of systemic therapies and the treatment of squamous cell cancer and basal cell cancer. 


Share Your Feedback:

Create your own user feedback survey

An Oncodermatologist Shares Treatment Updates for Basal and Squamous Cell Skin Cancers

Bookmark (0)

No account yet? Register

An Oncodermatologist Shares Treatment Updates for Basal and Squamous Cell Skin Cancers from Patient Empowerment Network on Vimeo.

Which non-melanoma skin cancer treatments are showing promise? Expert Dr. Silvina Pugliese shares updates on treatments for basal cell carcinoma and squamous cell cancer.

Silvina Pugliese, M.D., is a Clinical Assistant Professor of Dermatology and Attending Physician at the Stanford Medicine Outpatient Center and Stanford Cancer Institute. Learn more about Dr. Pugliese.

[ACT]IVATION TIP

“…if you have a diagnosis, a new diagnosis of basal cell cancer and squamous cell cancer, to know that the treatment options that are available to you are often going to be things that are fairly minimally invasive. So you might be recommended to try a topical cream for the earlier variants of basal cell cancer and squamous cell cancer, or you will have an outpatient procedure to have the skin cancers cut out, either with a surgical excision or with the procedure called Mohs micrographic surgery.”

Download Guide  |  Download Guide en español

See More from [ACT]IVATED Non-Melanoma Skin Cancer

Related Resources:

How Do Non-Melanoma Skin Cancers Impact Non-White Populations?

How Do Non-Melanoma Skin Cancers Impact Non-White Populations?

Occupational Exposures and Non-Melanoma Skin Cancer | Understanding Risk Factors

Occupational Exposures and Non-Melanoma Skin Cancer | Understanding Risk Factors

Hopeful Outcomes In Immunotherapy for Non-Melanoma Skin Cancers

Hopeful Outcomes In Immunotherapy for Non-Melanoma Skin Cancers


Transcript:

Mary Leer:

Dr. Pugliese, what promising treatments are available for newly diagnosed patients with non-melanoma skin cancers?

Dr. Silvina Pugliese:

For the purposes of answering this question, I’m going to focus on the two most common types of non-melanoma skin cancer, which are basal cell cancer and squamous cell cancer. And one of the things I tell my patients who are newly diagnosed is letting them know that most basal cancer and most squamous cell cancer can be treated with fairly, and I’ll call them simple procedures or treatment in the sense that most of these skin cancers will not need any radiation or any type of chemotherapy or immunotherapy. So that’s the majority, it’s not all.

But, for example, for basal cell cancer, it’s really just a very low number of patients that have advanced basal cell cancer or metastatic basal cell cancer. For a very early stages of the disease or certain subtypes such as superficial basal cell cancer, which just lives on the top surface of the skin, we can even treat that with a topical medication, such as a topical chemotherapy medication called Fluorouracil or another topical cream called imiquimod (Aldara, Zyclara). For other subtypes of basal cell cancer, which invade a little deeper into the skin, surgical excision is preferred. If it’s in a functionally sensitive area such as the face, for example, this will generally be treated with the type of procedure called Mohs micrographic surgery. 

A very similar treatment algorithm exists for squamous cell cancer. Early squamous cell cancers that are insight to in the very top layer of the skin can also be treated, it’s off-label treatment, but can be treated with topical fluorouracil cream or topical imiquimod cream. And for squamous cell cancers that are more invasive or for squamous cell cancers that have some more aggressive features, those would be treated with surgical excision and in certain areas, Mohs micrographic surgery would be utilized. 

Activation tip for this question is that if you have a diagnosis, a new diagnosis of basal cell cancer and squamous cell cancer, to know that the treatment options that are available to you are often going to be things that are fairly minimally invasive. So you might be recommended to try a topical cream for the earlier variants of basal cell cancer and squamous cell cancer, or you will have an outpatient procedure to have the skin cancers cut out, either with a surgical excision or with the procedure called Mohs micrographic surgery.


Share Your Feedback:

Create your own user feedback survey